Afya (NASDAQ:AFYA) Stock Price Down 4.8% – What’s Next?

Afya Limited (NASDAQ:AFYA)’s share price was down 4.8% on Wednesday. The stock traded as low as $10.22 and last traded at $10.3060. 196,933 shares changed hands during trading, an increase of 14% from the average session volume of 172,185 shares. The stock had previously closed at $10.83.

Analyst Ratings Changes

A number of equities research analysts have recently issued reports on AFYA shares. Weiss Ratings lowered Afya from a “hold (c)” rating to a “hold (c-)” rating in a research report on Friday, July 31st. JPMorgan Chase & Co. upgraded Afya from a “neutral” rating to an “overweight” rating and reduced their price objective for the stock from $21.00 to $19.00 in a research report on Wednesday, October 7th. Wall Street Zen upgraded Afya from a “hold” rating to a “buy” rating in a research report on Saturday, September 5th. Bradesco Corretora raised Afya to an “outperform” rating and set a $17.00 price objective on the stock in a research note on Thursday, September 24th. Finally, Zacks Research upgraded Afya from a “strong sell” rating to a “hold” rating in a report on Monday, October 5th. Two analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. Based on data from MarketBeat.com, the stock currently has an average rating of “Hold” and an average price target of $17.25.

Afya Price Performance

The stock’s fifty day moving average price is $13.83 and its 200-day moving average price is $14.27. The firm has a market cap of $959.16 million, a price-to-earnings ratio of 6.23, a P/E/G ratio of 1.83 and a beta of 0.34. The company has a current ratio of 2.20, a quick ratio of 2.20 and a debt-to-equity ratio of 0.39.

Afya (NASDAQ:AFYA) last released its quarterly earnings data on Friday, August 14th. The company reported $0.43 EPS for the quarter, beating analysts’ consensus estimates of $0.40 by $0.03. The firm had revenue of $187.80 million for the quarter, compared to analysts’ expectations of $189.62 million. Afya had a return on equity of 17.58% and a net margin of 20.55%. As a group, equities research analysts forecast that Afya Limited will post 1.72 earnings per share for the current fiscal year.

Insider Buying and Selling

In related news, insider Santos Welder Ferreira sold 4,161 shares of the firm’s stock in a transaction dated Monday, October 5th. The stock was sold at an average price of $13.30, for a total transaction of $55,341.30. Following the completion of the sale, the insider directly owned 35,000 shares of the company’s stock, valued at approximately $465,500. This trade represents a 10.63% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this hyperlink.

Institutional Inflows and Outflows

A hedge fund recently bought a new stake in Afya stock. Engineers Gate Manager LP bought a new position in shares of Afya Limited (NASDAQ:AFYA) in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The firm bought 21,882 shares of the company’s stock, valued at approximately $325,000. 88.02% of the stock is owned by hedge funds and other institutional investors.

About Afya

Afya Limited is a medical education and digital health company focused on Brazil. Through its educational platform, the company provides undergraduate medical education, medical residency preparation, specialization and continuing medical education programs, and other learning resources for students and physicians.

Afya also offers digital products and services intended to support healthcare professionals throughout their careers. These include clinical content, study tools, telemedicine and practice-management solutions, and subscription-based applications designed to assist physicians with education, clinical decision-making, and patient care.

The company has expanded through the development and acquisition of medical schools, education businesses, and health technology platforms serving different stages of the medical professional lifecycle.